These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26976326)

  • 1. Endothelin receptor antagonist macitentan or deletion of mouse mast cell protease 4 delays lesion development in atherosclerotic mice.
    Houde M; Desbiens L; Schwertani A; Pejler G; Iglarz M; D'Orléans-Juste P
    Life Sci; 2016 Aug; 159():71-75. PubMed ID: 26976326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice.
    Kim SJ; Lee HJ; Kim MS; Choi HJ; He J; Wu Q; Aldape K; Weinberg JS; Yung WK; Conrad CA; Langley RR; Lehembre F; Regenass U; Fidler IJ
    Clin Cancer Res; 2015 Oct; 21(20):4630-41. PubMed ID: 26106074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension.
    Iglarz M; Bossu A; Wanner D; Bortolamiol C; Rey M; Hess P; Clozel M
    Life Sci; 2014 Nov; 118(2):333-9. PubMed ID: 24582812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.
    Desbiens L; Lapointe C; Gharagozloo M; Mahmoud S; Pejler G; Gris D; D'Orléans-Juste P
    Mediators Inflamm; 2016; 2016():9797021. PubMed ID: 27610007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension].
    Avdeev SN
    Ter Arkh; 2016; 88(7):89-97. PubMed ID: 27459621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective improvement of pulmonary arterial hypertension with a dual ET
    Renshall L; Arnold N; West L; Braithwaite A; Pickworth J; Walker R; Alfaidi M; Chamberlain J; Casbolt H; Thompson AAR; Holt C; Iglarz M; Francis S; Lawrie A
    Pulm Circ; 2018; 8(1):2045893217752328. PubMed ID: 29261014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1.
    Houde M; Jamain MD; Labonté J; Desbiens L; Pejler G; Gurish M; Takai S; D'Orléans-Juste P
    J Pharmacol Exp Ther; 2013 Jul; 346(1):31-7. PubMed ID: 23596057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
    Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cell Degranulation Increases Mouse Mast Cell Protease 4-Dependent Vasopressor Responses to Big Endothelin-1 But Not Angiotensin I.
    Vincent L; Lapointe C; Lo M; Gagnon H; Pejler G; Takai S; Day R; D'Orléans-Juste P
    J Pharmacol Exp Ther; 2021 Feb; 376(2):213-221. PubMed ID: 33154104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macitentan: A Review in Pulmonary Arterial Hypertension.
    Keating GM
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):453-460. PubMed ID: 27580996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
    Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit
    Takahashi S; Horie R; Yokoyama Y
    Nihon Yakurigaku Zasshi; 2017; 149(1):49-58. PubMed ID: 28049880
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental Autoimmune Encephalomyelitis Potentiates Mouse Mast Cell Protease 4-Dependent Pressor Responses to Centrally or Systemically Administered Big Endothelin-1.
    Desbiens L; Lapointe C; Gendron L; Gharagozloo M; Vincent L; Pejler G; Gris D; D'Orléans-Juste P
    J Pharmacol Exp Ther; 2019 Sep; 370(3):437-446. PubMed ID: 31248979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.